欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FR/H/0341/001
药品名称AZZALURE 125 Speywood units
活性成分
    • Clostridium botulinum type A neurotoxin complex 0.0 0
剂型Powder for solution for injection
上市许可持有人Beaufour Ipsen Pharma 24 rue Erlanger 75016 Paris
参考成员国 - 产品名称France (FR)
互认成员国 - 产品名称
    • Slovakia (SK)
    • Croatia (HR)
    • Hungary (HU)
      AZZALURE 10 Speywood egység/0,05 ml por oldatos injekcióhoz
    • Latvia (LV)
    • Lithuania (LT)
      Azzalure 125 Speywood vienetai milteliai injekciniam tirpalui
    • Estonia (EE)
    • Bulgaria (BG)
      Azzalure
    • Romania (RO)
    • Slovenia (SI)
    • Malta (MT)
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Cyprus (CY)
    • Czechia (CZ)
许可日期2009/01/28
最近更新日期2025/01/24
药物ATC编码
    • M03AX01 botulinum toxin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Biological: Other
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase